Researchers gathered 2012–2017 data from a Dutch national surveillance network on frequently performed surgical procedures across specialties. They divided 387,919 patients into five categories:
• Underweight (BMI is less than 18.5 kg/m2): 3,676 patients
• Normal weight (BMI, is between 18.5 and 25 kg/m2): 116,778
• Overweight (BMI is between 25 and 30 kg/m2): 154,339
• Obese (BMI is between 30 and 40 kg/m2): 104,288
• Morbidly obese (BMI is more than 40 kg/m2): 8,838
Researchers found that when BMI increased from normal to morbidly obese, there was an increase in the risk of developing surgical site infections in almost all surgery types.
“The results of our research provide evidence for the need of preventive programs targeting SSI in overweight and obese patients, as well as for the prevention of obesity in the general population,” study authors concluded.
More articles on healthcare quality:
Ohio senator reintroduces bill to tackle antibiotic resistance
1st effective treatments found for Ebola, scientists say
Physicians should screen adults for illicit drug use, panel says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
